Article Details

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 2024-05-03 20:32:05

Tags for this article:

Click the tags to see associated articles and topics

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4). View article details on hiswai:

Summary

The article text explains that Dianthus Therapeutics, based in both New York City and Waltham, designs novel antibody therapeutics and has granted equity awards to new employees related to its compensation strategy.

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo